PMID- 23043872 OWN - NLM STAT- MEDLINE DCOM- 20130507 LR - 20220310 IS - 1573-2509 (Electronic) IS - 0920-9964 (Print) IS - 0920-9964 (Linking) VI - 142 IP - 1-3 DP - 2012 Dec TI - North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. PG - 77-82 LID - S0920-9964(12)00535-X [pii] LID - 10.1016/j.schres.2012.09.012 [doi] AB - The North American Prodrome Longitudinal Study (NAPLS) is a consortium of eight programs focusing on the psychosis prodrome. Funded by the National Institute of Mental Health (NIMH), the sites are located at Emory University, Harvard University, University of Calgary, UCLA, UCSD, University of North Carolina Chapel Hill, Yale University, and Zucker Hillside Hospital. Although the programs initially developed independently, they previously collaborated to combine their historical datasets and to produce a series of analyses on predictors of psychosis in one of the largest samples of longitudinally followed prodromal subjects worldwide. This led to the development of a five year prospective study "Predictors and Mechanisms of Conversion to Psychosis", (also known as NAPLS-2) with three major aims: (1) to prospectively test the prediction algorithm developed in NAPLS-1, (2) to investigate the neuroanatomical, neurophysiological, neurocognitive, and neurohormonal factors that may contribute to the development of psychosis, and (3) to develop a repository of DNA, RNA, and plasma from participants meeting diagnostic criteria for a clinical high risk (CHR) state and from demographically similar healthy subjects. Funded by NIMH in 2008, NAPLS-2 will generate the largest CHR for psychosis sample with 720 CHR and 240 healthy comparison subjects, and thus will provide statistical power and scientific scope that cannot be duplicated by any single site study. This paper describes the overall methodology of the NAPLS-2 project and reports on the ascertainment and demographics at the midway point of the study with (360 CHR) and 180 controls. CI - Copyright (c) 2012 Elsevier B.V. All rights reserved. FAU - Addington, Jean AU - Addington J AD - Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. jmadding@ucalgary.ca FAU - Cadenhead, Kristin S AU - Cadenhead KS FAU - Cornblatt, Barbara A AU - Cornblatt BA FAU - Mathalon, Daniel H AU - Mathalon DH FAU - McGlashan, Thomas H AU - McGlashan TH FAU - Perkins, Diana O AU - Perkins DO FAU - Seidman, Larry J AU - Seidman LJ FAU - Tsuang, Ming T AU - Tsuang MT FAU - Walker, Elaine F AU - Walker EF FAU - Woods, Scott W AU - Woods SW FAU - Addington, Jack A AU - Addington JA FAU - Cannon, Tyrone D AU - Cannon TD LA - eng GR - U01MH082004-01A1/MH/NIMH NIH HHS/United States GR - P50 MH080272/MH/NIMH NIH HHS/United States GR - U01MH082022/MH/NIMH NIH HHS/United States GR - U01 MH081988/MH/NIMH NIH HHS/United States GR - U01MH081988/MH/NIMH NIH HHS/United States GR - U01 MH076989/MH/NIMH NIH HHS/United States GR - K24 MH076191/MH/NIMH NIH HHS/United States GR - U01 MH081857-05/MH/NIMH NIH HHS/United States GR - U01MH081984/MH/NIMH NIH HHS/United States GR - MH081902/MH/NIMH NIH HHS/United States GR - K24 MH76191/MH/NIMH NIH HHS/United States GR - U01 MH082022/MH/NIMH NIH HHS/United States GR - U01 MH081984/MH/NIMH NIH HHS/United States GR - R01 MH60720/MH/NIMH NIH HHS/United States GR - R01 MH060720/MH/NIMH NIH HHS/United States GR - U01 MH081928/MH/NIMH NIH HHS/United States GR - U01 MH081857/MH/NIMH NIH HHS/United States GR - U01 MH082004/MH/NIMH NIH HHS/United States GR - U01 MH081944/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20121006 PL - Netherlands TA - Schizophr Res JT - Schizophrenia research JID - 8804207 SB - IM MH - *Biomedical Research MH - Cooperative Behavior MH - Female MH - Humans MH - Longitudinal Studies MH - Male MH - Neuropsychological Tests MH - North America MH - *Patient Selection MH - Referral and Consultation MH - Schizophrenia/*diagnosis/*therapy MH - Schizophrenic Psychology PMC - PMC3502644 MID - NIHMS411004 COIS- Conflict of interest There are no conflicts of interest for any of the authors with respect to the data in this paper or for the study. EDAT- 2012/10/10 06:00 MHDA- 2013/05/08 06:00 PMCR- 2013/12/01 CRDT- 2012/10/10 06:00 PHST- 2012/06/01 00:00 [received] PHST- 2012/09/12 00:00 [revised] PHST- 2012/09/17 00:00 [accepted] PHST- 2012/10/10 06:00 [entrez] PHST- 2012/10/10 06:00 [pubmed] PHST- 2013/05/08 06:00 [medline] PHST- 2013/12/01 00:00 [pmc-release] AID - S0920-9964(12)00535-X [pii] AID - 10.1016/j.schres.2012.09.012 [doi] PST - ppublish SO - Schizophr Res. 2012 Dec;142(1-3):77-82. doi: 10.1016/j.schres.2012.09.012. Epub 2012 Oct 6.